Resurgent Financial Advisors LLC Amgen Inc Transaction History

Resurgent Financial Advisors LLC

$170 Million
Q3 2024

A detailed history of Resurgent Financial Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Resurgent Financial Advisors LLC holds 3,810 shares of AMGN stock, worth $1 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

3,810

Previous 3,662 4.04%

Holding current value

$1 Million

Previous $1.14 Million 7.26%

% of portfolio

0.72%

Previous 0.7%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $45,788 - $49,932	148 Added 4.04%	3,810 $1.23 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $91,437 - $111,119	-348 Reduced 8.68%	3,662 $1.14 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $21,240 - $25,640	-79 Reduced 1.93%	4,010 $1.14 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $51,907 - $58,557	203 Added 5.22%	4,089 $1.18 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $116,321 - $144,416	532 Added 15.86%	3,886 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $26,783 - $31,671	-125 Reduced 3.59%	3,354 $744,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $114,249 - $139,251	-506 Reduced 12.7%	3,479 $841,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $182,536 - $231,934	797 Added 25.0%	3,985 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $371,705 - $419,216	1,656 Added 108.09%	3,188 $719,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $17,764 - $19,768	77 Added 5.29%	1,532 $373,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $52,624 - $58,216	240 Added 19.75%	1,455 $352,000
Q4 2021 May 16, 2022	BUY	$198.88 - $227.6 $241,639 - $276,534	1,215 New	1,215 $273,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.

Account

Resurgent Financial Advisors LLC Amgen Inc Transaction History